N-[3-(5-ethyl-1,3-benzoxazol-2-yl)-4-hydroxyphenyl]propanamide structure
|
Common Name | N-[3-(5-ethyl-1,3-benzoxazol-2-yl)-4-hydroxyphenyl]propanamide | ||
|---|---|---|---|---|
| CAS Number | 925130-65-0 | Molecular Weight | 310.3 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H18N2O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | N-[3-(5-ethyl-1,3-benzoxazol-2-yl)-4-hydroxyphenyl]propanamide |
|---|
| Molecular Formula | C18H18N2O3 |
|---|---|
| Molecular Weight | 310.3 |
| InChIKey | KNJUDVCKPLWVGZ-UHFFFAOYSA-N |
| SMILES | CCC1=CC2=C(C=C1)OC(=N2)C3=C(C=CC(=C3)NC(=O)CC)O |
|
Name: qHTS assay for inhibitors of human lactate dehydrogenase
Source: NCGC
Target: N/A
External Id: LDHA
|
|
Name: Primary qHTS Assay for Foot and Mouth Disease Virus Antivirals against NCGC Sytravon ...
Source: NCGC
External Id: stopgo-p2-SytraCBC-dual-FF
|
|
Name: Primary qHTS Assay for Foot and Mouth Disease Virus Antivirals against NCGC Sytravon ...
Source: NCGC
External Id: stopgo-p2-SytraCBC-dual-Ren
|